title: Long-term survival of a patient with primary papillary serous carcinoma of the peritoneum treated by subtotal peritonectomy plus intraoperative chemohyperthermia.
abstract: We report the long-term survival of a patient with primary papillary serous carcinoma of the peritoneum, treated by subtotal peritonectomy combined with continuous hyperthermic peritoneal perfusion. After subtotal peritonectomy and continuous hyperthermic peritoneal perfusion, early postoperative intraperitoneal chemotherapy with cisplatin and three cycles of cisplatin-based intravenous chemotherapy were administered. The patient currently remains alive 23 months after surgery. This long-term survival suggests that treatment of primary papillary serous carcinoma of the peritoneum requires aggressive cytoreduction surgery followed by chemotherapy using adequate methods to enhance chemosensitivity.
authors.affiliation: Second Department of Surgery, Kanazawa University, School of Medicine, Takaramachi 13-1, Kanazawa, Ishikawa 920-8641, Japan.
authors.forename: Hideyuki
authors.initials: H
authors.lastname: Ajisaka
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Yonemura
authors.forename: Etsuro
authors.initials: E
authors.lastname: Bando
authors.forename: Sachio
authors.initials: S
authors.lastname: Fushida
authors.forename: Genichi
authors.initials: G
authors.lastname: Nishimura
authors.forename: Koichi
authors.initials: K
authors.lastname: Miwa
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000379:methods*; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D003131:Combined Modality Therapy; D018283:Cystadenocarcinoma, Papillary / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006979:Hyperthermia, Induced / Q000379:methods*; D010534:Peritoneal Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D010537:Peritoneum / Q000473:pathology / Q000601:surgery; D015996:Survival Rate; D017741:Survivors
chemical_list: D002945:Cisplatin